Quest Diagnostics (DGX) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $246.45 -0.4%
Revenue Growth %: +7.8%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +7.8%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.19, in-line with the analyst estimate of $1.19. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.85 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
